Bimeda News

Bimeda Biologicals® Launches Stimulator® 5 + PMH

Bimeda Biologicals® is pleased to announce the newest addition to their Stimulator® line of modified live virus (MLV) vaccines: Stimulator® 5 + PMH. With this launch, Bimeda Biologicals adds to their broad portfolio of cattle vaccines another effective combination vaccine that helps protect cattle against some of the most common—and costly—viral and bacterial pathogens associated with Bovine Respiratory Disease (BRD).

This vaccine takes Bimeda Biologicals 5-way viral vaccine—that has proven its ability to go toe-to-toe with some of the most commonly used and more recognized MLV vaccine brands in large-scale research trials—and combines it with bacterial antigen to provide veterinarians and cattle producers a new, cost-effective option to help keep the cattle that they care for healthy.

Stimulator 5 + PMH has been shown to be effective for the vaccination of healthy cattle five months of age or older against Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea Type 1a (BVD I), Bovine Viral Diarrhea Type 2 (BVD II), Parainfluenza3 (PI3), Bovine Respiratory Syncytial Virus (BRSV) as well as Mannheimia haemolytica and Pasteurella multocida.

This product, like other combination vaccines, requires the user to aseptically rehydrate the freeze-dried modified live vaccine with the accompanying bottle of bacterin-toxoid. Mix reconstituted vial well. Administer 2.0 mL subcutaneously in the side of the neck followed by a second dose of Mannheimia haemolytica–Pasteurella multocida (PMH BAC) to be given 14 to 28 days after the first dose.

For more information about the new products, visit the Bimeda Biologicals Products page

Jim Lovin, Strategic Accounts Manager-Swine
Bimeda® Announces Sponsorship of Hagyard Equine Me...